(-)-N-Porphynorapomorphine


SMILES CCCN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O
InChIKey BTGAJCKRXPNBFI-OAHLLOKOSA-N

Chemical properties

Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 2
Molecular weight (Da) 295.2

Drug properties

Molecular type Small molecule
Endogenous/Surrogate Surrogate
Approved drug No

Database connections

Ligand site mutations D2 D5

Bioactivity

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
D2 DRD2 Human Dopamine A pKi 7.5 8.2 8.9 Guide to Pharmacology
D3 DRD3 Human Dopamine A pKi 8.4 8.55 8.7 Guide to Pharmacology
D1 DRD1 Rat Dopamine A pKi 5.47 6.2 6.47 ChEMBL
D1 DRD1 Rat Dopamine A pIC50 6.19 6.19 6.19 ChEMBL
D1 DRD1 Human Dopamine A pKi 5.82 7.04 9.0 ChEMBL
D1 DRD1 Human Dopamine A pKd 5.74 5.74 5.74 ChEMBL
D1 DRD1 Human Dopamine A pEC50 5.72 7.34 8.96 ChEMBL
D2 DRD2 Rat Dopamine A pKi 7.27 8.77 9.74 ChEMBL
D2 DRD2 Rat Dopamine A pIC50 8.0 8.16 8.32 ChEMBL
D2 DRD2 Rat Dopamine A pKd 6.28 7.04 8.05 ChEMBL
D3 DRD3 Human Dopamine A pKi 8.72 8.94 9.36 ChEMBL
D2 DRD2 Human Dopamine A pKi 7.3 8.97 10.13 ChEMBL
D2 DRD2 Human Dopamine A pKd 7.7 7.7 7.7 ChEMBL
D2 DRD2 Human Dopamine A pEC50 7.6 9.25 10.4 ChEMBL
D2 DRD2 Human Dopamine A pKi 8.92 8.92 8.92 PDSP Ki database
D3 DRD3 Human Dopamine A pKi 8.68 8.68 8.68 PDSP Ki database